Breast conserving surgery in patients with multifocal/multicentric breast cancer
dc.contributor.author | Eryilmaz, M. A. | |
dc.contributor.author | Muslumanoglu, M. | |
dc.contributor.author | Ozmen, V. | |
dc.contributor.author | Igci, A. | |
dc.contributor.author | Koc, M. | |
dc.date.accessioned | 2020-03-26T18:13:53Z | |
dc.date.available | 2020-03-26T18:13:53Z | |
dc.date.issued | 2011 | |
dc.department | Selçuk Üniversitesi | en_US |
dc.description.abstract | Purpose: To retrospectively evaluate the outcome of patients with multifocal (MF) and multicentric (MC) breast cancer treated with conservative surgery Methods: We evaluated 59 patients who had undergone breast conserving surgery (BCS) for MF/MC cancer between 1998-2008. We used sentinel lymph node (SLN) biopsy for all 59 patients and we performed axillary lymph node dissection in those with positive SLN. Local control, overall survival (OS), disease-free survival (DFS) and identification of predictive factors for recurrence were evaluated. Results: Twenty patients with modified radical mastectomy because of persistent positive margins were excluded from the study. Evaluated were 55 patients with MF (93.2%) and 4 (6.8%) with MC disease. Thirty-four patients (57.6%) had 2, 20 patients (33.9%) had 3 and 5(8.5%) had 4 or more tumor foci. Median follow up time was 20 months (range 297). The projected 5- and 8-year OS were 95% and 89% respectively, and DFS 92.3%. At multivariate analysis, overexpression of human epidermal growth factor receptor 2 (HER-2) was associated with a higher ipsilateral breast cancer recurrence. Menopausal status, MF/MC disease, number of tumor foci (2 vs. >= 3), histological grade, extracapsular extension (ECE), lymphovascular invasion (LVI), and hormone receptor status were not associated with ipsilateral breast cancer recurrence. Conclusion: Our study demonstrates that in selected patients with MF/MC breast cancer, wide conservative surgery is a safe therapy. | en_US |
dc.identifier.endpage | 453 | en_US |
dc.identifier.issn | 1107-0625 | en_US |
dc.identifier.issue | 3 | en_US |
dc.identifier.pmid | 22006748 | en_US |
dc.identifier.scopusquality | Q3 | en_US |
dc.identifier.startpage | 450 | en_US |
dc.identifier.uri | https://hdl.handle.net/20.500.12395/26208 | |
dc.identifier.volume | 16 | en_US |
dc.identifier.wos | WOS:000295563900010 | en_US |
dc.identifier.wosquality | Q4 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | ZERBINIS MEDICAL PUBL | en_US |
dc.relation.ispartof | JOURNAL OF BUON | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.selcuk | 20240510_oaig | en_US |
dc.subject | breast cancer | en_US |
dc.subject | conservative surgery | en_US |
dc.subject | multicentric | en_US |
dc.subject | multifocal | en_US |
dc.title | Breast conserving surgery in patients with multifocal/multicentric breast cancer | en_US |
dc.type | Article | en_US |